Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Bcr-Abl
    (3)
  • Apoptosis
    (2)
  • Aurora Kinase
    (2)
  • Autophagy
    (2)
  • FLT
    (2)
  • Src
    (2)
  • CDK
    (1)
  • DNA Alkylation
    (1)
  • IGF-1R
    (1)
  • JAK
    (1)
Filter
Search Result
Results for "

abl1 (t315i)

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    4
    TargetMol | Inhibitors_Agonists
AT9283
J-504568
T3068896466-04-9
AT9283 (J-504568) is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1.1 nM), Aurora A, Aurora B and Abl(T315I).
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Rebastinib
DCC-2036, DCC2036, DCC 2036
T26401020172-07-9
DCC-2036 (Rebastinib (DCC-2036)) is a conformational control Bcr-Abl inhibitor for Abl1(WT, IC50: 0.8 nM) and Abl1(T315I, IC50: 4 nM), also inhibits LYN, SRC, HCK, FGR, FLT3, KDR, and Tie-2, and low activity to c-Kit. Rebastinib aimed at the Angiopoietin2-Tie2 pathway.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
BCR-ABL-IN-2
T10489897369-18-5
BCR-ABL-IN-2 is a BCR-ABL1 tyrosine kinase inhibitor (IC50s: 57 nM, 773 nM for ABL1 native and ABL1 T315I).
  • Inquiry Price
6-8 weeks
Size
QTY
URMC-099
T60571229582-33-5
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19 42 14 150 nM, for MLK1 MLK2 MLK3 DLK), and also inhibits LRRK2 activity (IC50: 11 nM).
  • Inquiry Price
Size
QTY